SG Americas Securities, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2024$1,364
+603.1%
53,865
+756.8%
0.01%
+700.0%
Q1 2024$194
+28.5%
6,287
+68.0%
0.00%0.0%
Q4 2023$151
+22.8%
3,742
-19.6%
0.00%0.0%
Q3 2023$123
-62.0%
4,656
-76.2%
0.00%
-75.0%
Q1 2023$324
-99.8%
19,545
-8.3%
0.00%
+33.3%
Q3 2022$212,000
-80.9%
21,316
-82.6%
0.00%
-75.0%
Q2 2022$1,111,000
+263.1%
122,311
+305.9%
0.01%
+500.0%
Q1 2022$306,000
+29.1%
30,134
+112.3%
0.00%
+100.0%
Q4 2021$237,000
-80.1%
14,195
-44.0%
0.00%
-83.3%
Q3 2021$1,188,000
+4.3%
25,337
+35.6%
0.01%
+20.0%
Q2 2021$1,139,000
+27.5%
18,680
+28.9%
0.01%0.0%
Q1 2021$893,000
-32.2%
14,495
-21.8%
0.01%
-28.6%
Q4 2020$1,318,000
+131.6%
18,532
+22.3%
0.01%
+75.0%
Q3 2020$569,000
-13.7%
15,158
-25.0%
0.00%
-20.0%
Q2 2020$659,000
+53.6%
20,198
+36.5%
0.01%
+25.0%
Q1 2020$429,000
+123.4%
14,792
+170.0%
0.00%
+100.0%
Q4 2019$192,000
-59.7%
5,478
-69.0%
0.00%
-33.3%
Q2 2019$476,00017,6470.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$373,797,00067.28%
Darwin Global Management, Ltd. 2,090,149$128,753,00025.21%
Affinity Asset Advisors, LLC 577,500$35,574,00012.08%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$1,913,356,0009.64%
Perceptive Advisors 7,756,928$477,827,0006.04%
Opaleye Management Inc. 583,767$35,960,0005.28%
MIZUHO MARKETS AMERICAS LLC 171,923$10,590,0004.93%
VIKING GLOBAL INVESTORS LP 26,620,991$1,639,853,0004.88%
Fernwood Investment Management, LLC 151,085$9,307,0003.42%
HHLR ADVISORS, LTD. 5,362,014$330,300,0003.26%
View complete list of BRIDGEBIO PHARMA INC shareholders